QGEN
Qiagen·NYSE
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Signals Analysis
Bullish signal 6
Bearish signal 1
Consensus Rating "Buy"
Ample Liquidity
High Gross Profit Margin
High Cash/net Profit Ratio
Revenue Beats Expectation
Bullish Abandoned Baby
EPS Below Expectations
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About QGEN
Qiagen N.V.
A leading provider of molecular diagnostics and sample preparation technologies for life sciences and molecular diagnostics markets
Life Science Tools and Services
--
01/10/2018
New York Stock Exchange
5,765
12-31
Common stock
Hulsterweg 82, 5912 PL Venlo, The Netherlands
--
Qiagen N.V. is a Dutch holding company whose subsidiary is the main provider of Sample and Assay Technologies. The company is a global leader in Sample to Insight solutions, serving more than 500,000 clients across two broad customer bases: Molecular Diagnostics (Human Healthcare) and Life Sciences (Academia, Pharma R&D and Industrial Applications, primarily Forensic Medicine). The company operates its products in more than 100 countries.
Earnings Call
Q1/2025
Estimate EPS0.51
Actual EPS0.55
Estimate Revenue476.78M
Actual Revenue483.00M
Qiagen's Q1 2025: Unpacking Contradictions in Growth Expectations, Tariff Strategies, and Capital Performance
May 19,2025 10:54
Earnings Decrypt
Earnings Decrypt
Q2/2025
Estimate EPS0.6
Actual EPS0.6
Estimate Revenue524.02M
Actual Revenue534.00M
Contradictions Unveiled: Qiagen's 2025Q2 Earnings Call Highlights Divergent Views on Market Performance and Growth
Aug 13,2025 04:10
Earnings Decrypt
Earnings Decrypt
Q3/2025
Estimate EPS0.58
Actual EPS0.61
Estimate Revenue525.71M
Actual Revenue533.00M
Qiagen's Q3 2025 Earnings Call: Contradictions Emerge on M&A Strategy, QIAstat Growth, Tariff Impact on Margins, and QIAcuity's Market Position
Nov 05,2025 04:01
Earnings Decrypt
Earnings Decrypt
Company Financials
EPS
QGEN has released its 2025 Q3 earnings. EPS was reported at 0.61, versus the expected 0.58, beating expectations. The chart below visualizes how QGEN has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
QGEN has released its 2025 Q3 earnings report, with revenue of 532.58M, reflecting a YoY change of 6.12%, and net profit of 130.04M, showing a YoY change of 32.62%. The Sankey diagram below clearly presents QGEN's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
